The development phase required selection of high-risk prescribing outcome measures and design of intervention components : ( @ ) educational material ( the usual care comparison ) , ( @ ) feedback of practice rates of high-risk prescribing received by both intervention arms and ( @ ) a theory-informed behaviour change component to be received by one intervention arm .